Answers are grounded in this paper and cite their sources.
Glioblastoma is a brain neoplasm with limited 5-year survival rates. Developments of new treatment regimens that improve patient survival in patients with glioblastoma are needed. It is likely that a number of existing drugs used in other conditions have potential anticancer effects that offer significant survival benefit to glioblastoma patients. Identification of such drugs could provide a novel treatment paradigm.
No takes yet. Share an insight, caveat, or question.
Rundle‐Thiele et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: